Related Experiment Videos
Salsolinol and norsalsolinol in human urine samples
F Musshoff1, T Daldrup, W Bonte
1Institute of Legal Medicine, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
Pharmacology, Biochemistry, and Behavior
|September 23, 1997
Summary
Urine levels of salsolinol and norsalsolinol vary greatly between individuals. However, the dopamine-aldehyde adduct ratio (DAAR) effectively distinguishes alcoholics from nonalcoholics, indicating its potential as a biomarker.
Area of Science:
- Biochemistry
- Neuroscience
- Toxicology
Background:
- Tetrahydroisoquinoline alkaloids, including salsolinol and norsalsolinol, are endogenous compounds.
- These alkaloids are implicated in various physiological and pathological processes, including alcohol metabolism and neurotoxicity.
Purpose of the Study:
- To investigate the utility of salsolinol and norsalsolinol urine concentrations as biomarkers for alcoholism.
- To explore the potential of the dopamine-aldehyde adduct ratio (DAAR) as a diagnostic marker for alcohol dependence.
Main Methods:
- Quantification of salsolinol and norsalsolinol in human urine samples from alcoholics and nonalcoholics using chromatographic techniques.
- Calculation of the dopamine-aldehyde adduct ratio (DAAR) by dividing norsalsolinol concentration by salsolinol concentration.
Main Results:
- Salsolinol and norsalsolinol were detected in urine, with significant interindividual variability.
- Individual alkaloid levels did not reliably differentiate between alcoholics and nonalcoholics.
- The DAAR showed significant differences between alcoholics (median 1.3) and nonalcoholics (median 0.6).
Conclusions:
- Individual urine levels of salsolinol and norsalsolinol are insufficient biomarkers for alcoholism.
- The DAAR is a promising biomarker for distinguishing alcoholics from nonalcoholics.
- The DAAR may reflect the functional state of the dopaminergic system in the context of alcohol consumption.